Increased platelet activating factor in the tracheal aspirates from neonates with patent ductus arteriosus.
We investigated platelet-activating factor (PAF) in the tracheal aspirate from 3 intubated low birth weight infants with symptomatic patent ductus arteriosus (PDA). PAF increased with the onset of symptomatic PDA and decreased to the control range soon after the ductal closure. The concentration of PAF in 26 samples taken during symptomatic PDA (median 16 pg/micrograms lipid phosphorus, range 1.4-1,200 pg/micrograms lipid phosphorus) was significantly higher than that of 31 samples from the same three patients during the periods without symptomatic PDA (median 1.9 pg/micrograms lipid phosphorus, range 0-12 pg/micrograms lipid phosphorus; P < 0.001). All 3 infants later developed chronic lung disease. These results suggest that large shunting PDA provokes PAF release to the air way of the neonate and that PAF might play a role in chronic lung disease developing after symptomatic PDA.
Koyama
N
N
Department of Pediatrics, Saitama Medical School, Japan.
Ogawa
Y
Y
Kamiya
K
K
Eguchi
H
H
Tanaka
T
T
Takasaki
J
J
Ohama
Y
Y
Itakura
Y
Y
Kaneko
K
K
D004374:Ductus Arteriosus, Patent / Q000378:metabolism* / Q000601:surgery; D005260:Female; D006801:Humans; D007223:Infant; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008297:Male; D010972:Platelet Activating Factor / Q000378:metabolism*; D013396:Suction; D014132:Trachea / Q000378:metabolism*
D010972:Platelet Activating Factor